Leptomeningeal metastases more common in NSCLC patients with EGFR mutations
(International Association for the Study of Lung Cancer) Leptomeningeal metastases (LM), a devastating complication and predictor of poor survival in lung cancer patients, was found to be more prevalent in non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations. Patients receiving tyrosine kinase inhibitors (TKIs) targeting EGFR mutations had a longer overall survival (OS) than those who did not receive TKIs, demonstrating the effectiveness of TKIs for LM therapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 15, 2016 Category: Global & Universal Source Type: news
Q&A: Valerie Harper’s Cancer
WebMD Medical News By Kathleen Doheny Reviewed by Brunilda Nazario, MD March 6, 2013 — Actress Valerie Harper, best known for her role as Rhoda Morgenstern on The Mary Tyler Moore Show and Rhoda in the 1970s, has learned she has leptomeningeal carcinomatosis. The condition happens when cancer spreads to the brain and spinal cord. Now 73, Harper told People magazine she received the diagnosis in January. The American Cancer Society has no specific statistics on this complication. Some research estimates it happens in about 5% to 10% of patients with cancer. WebMD asked Henry S. Friedman, MD, deputy directo...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - March 7, 2013 Category: Consumer Health News Authors: mreal197 Tags: WebMD News Source Type: news